The term "MTPC1" may represent a typographical error or misinterpretation of established abbreviations. Below are related antibodies with nomenclature similarities:
Applications: Western blot, immunohistochemistry, immunofluorescence
Species Reactivity: Human, mouse, rat
Conjugates: HRP, FITC, PE, Alexa Fluor® variants (e.g., AF488, AF647)
Role in Disease: Linked to abetalipoproteinemia due to MTTP dysfunction .
While "MTPC1" lacks scientific recognition, novel antibody development typically follows these steps:
Target Identification: CRISPR screens or proteomic studies to define disease-associated biomarkers.
Epitope Mapping: Phage display/hybridoma technology for antibody generation.
Validation: Binding affinity (e.g., SPR, ELISA) and functional assays (e.g., ADCC, apoptosis).
Confirm target nomenclature via genomic databases (e.g., NCBI Gene, UniProt).
Explore antibodies against analogous targets (e.g., MTFP1, MTTP) with established roles in metabolic or oncologic pathways.
Consult antibody repositories (CiteAb, Antibody Registry) for updated listings.